Digitalis toxicity is a frequently encountered clinical problem. Drug interactions leading to
digitalis toxicity are very common. Within this group, the interaction of digitalis and verapamil …

When Butler and Chen first produced digoxin antibodies in 19671 it was hoped that the
availability of a radioimmunoassay of serum levels of digoxin would lead to safer and more …

Digitalis toxicity continues to be a problem for pediatric patients undergoing therapy with
cardiac glycosides for heart failure or arrhythmias, as well as in accidental ingestions. In this …

Digitalis products are widely used and toxicity from overdosage is common. This case
illustrates some of the clinical manifestations of digoxin toxicity, and the importance of proper …

One hundred fifty patients with potentially life-threatening digitalis toxicity were treated with
digoxin-specific antibody fragments (Fab) purified from immunoglobulin G produced in …

Many studies and cases of digitalis intoxication have been reported since the time of William
Withering's first publication in 1785. Recognition and management of digitalis toxicity is …

T he value of digitalis glycosides in the treatment of cardiovascular diseases has been
known to clinicians for centuries, and digoxin remains one of the most commonly prescribed …

Background. Because life-threatening digitalis intoxication is unusual in children, treatment
with digoxin-specific—antibody Fab fragments (Fab) has rarely been reported. We describe …

Digitalis intoxication is among the most common serious adverse drug reactions in clinical
medicine. While the recent development of a radioimmunoassay to accurately measure …

An observational surveillance study was conducted to monitor the safety and effectiveness
of treatment with Digoxin Immune Fab (Ovine)(Digibind) in patients with digitalis intoxication …